COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | NOTE 3.000% 6/1 | 68269GAB3 | 40,222 | 48,599,000 | PRN | | DFND | 1 | 48,599,000 | 0 | 0 |
89BIO INC | COM | 282559103 | 1,630 | 506,100 | SH | | DFND | 1 | 506,100 | 0 | 0 |
ACCOLADE INC | NOTE 0.500% 4/0 | 00437EAB8 | 59,134 | 92,624,000 | PRN | | DFND | 1 | 92,624,000 | 0 | 0 |
ACUTUS MED INC | COM | 005111109 | 2,966 | 2,648,386 | SH | | DFND | 1 | 2,648,386 | 0 | 0 |
ADAPTHEALTH CORP | COMMON STOCK | 00653Q102 | 201,160 | 11,150,797 | SH | | DFND | 1 | 11,150,797 | 0 | 0 |
AERIE PHARMACEUTICALS INC | NOTE 1.500%10/0 | 00771VAB4 | 133,036 | 157,390,000 | PRN | | DFND | 1 | 157,390,000 | 0 | 0 |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 35,213 | 4,695,020 | SH | | DFND | 1 | 4,695,020 | 0 | 0 |
ALECTOR INC | COM | 014442107 | 10,721 | 1,055,192 | SH | | DFND | 1 | 1,055,192 | 0 | 0 |
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 15,830 | 2,420,547 | SH | | DFND | 1 | 2,420,547 | 0 | 0 |
AMEDISYS INC | COM | 023436108 | 20,919 | 199,000 | SH | | DFND | 1 | 199,000 | 0 | 0 |
AN2 THERAPEUTICS INC | COM | 037326105 | 5,553 | 716,538 | SH | | DFND | 1 | 716,538 | 0 | 0 |
ANAPTYSBIO INC | COM | 032724106 | 15,672 | 772,000 | SH | | DFND | 1 | 772,000 | 0 | 0 |
ANNEXON INC | COM | 03589W102 | 2,201 | 583,913 | SH | | DFND | 1 | 583,913 | 0 | 0 |
APELLIS PHARMACEUTICALS INC | NOTE 3.500% 9/1 | 03753UAB2 | 76,456 | 51,885,000 | PRN | | DFND | 1 | 51,885,000 | 0 | 0 |
APOLLO ENDOSURGERY INC | COM | 03767D108 | 6,388 | 1,750,000 | SH | | DFND | 1 | 1,750,000 | 0 | 0 |
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 22,851 | 2,473,000 | SH | | DFND | 1 | 2,473,000 | 0 | 0 |
BENEFITFOCUS INC | NOTE 1.250%12/1 | 08180DAB2 | 5,907 | 6,500,000 | PRN | | DFND | 1 | 6,500,000 | 0 | 0 |
BIOGEN INC | COM | 09062X103 | 101,970 | 500,000 | SH | Call | DFND | 1 | 500,000 | 0 | 0 |
BROOKDALE SR LIVING INC | COM | 112463104 | 39,010 | 8,592,461 | SH | | DFND | 1 | 8,592,461 | 0 | 0 |
BUTTERFLY NETWORK INC | *W EXP 02/12/202 | 124155110 | 296 | 733,333 | SH | | DFND | 1 | 733,333 | 0 | 0 |
CABALETTA BIO INC | COM | 12674W109 | 492 | 464,252 | SH | | DFND | 1 | 464,252 | 0 | 0 |
CAREMAX INC | COM CL A | 14171W103 | 57,576 | 15,861,090 | SH | | DFND | 1 | 15,861,090 | 0 | 0 |
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 484 | 672,000 | SH | | DFND | 1 | 672,000 | 0 | 0 |
CENTENE CORP DEL | COM | 15135B101 | 48,972 | 578,800 | SH | | DFND | 1 | 578,800 | 0 | 0 |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 53,009 | 5,876,805 | SH | | DFND | 1 | 5,876,805 | 0 | 0 |
CYTOKINETICS INC | COM NEW | 23282W605 | 45,589 | 1,160,315 | SH | | DFND | 1 | 1,160,315 | 0 | 0 |
DA32 LIFE SCNCE TEC ACQSTN C | CLASS A COM | 23312M106 | 15,504 | 1,600,000 | SH | | DFND | 1 | 1,600,000 | 0 | 0 |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 62,867 | 3,512,123 | SH | | DFND | 1 | 3,512,123 | 0 | 0 |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 82,200 | 6,250,964 | SH | | DFND | 1 | 6,250,964 | 0 | 0 |
DELCATH SYS INC | COM NEW | 24661P807 | 1,995 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
DYNAVAX TECHNOLOGIES CORP | NOTE 2.500% 5/1 | 268158AD4 | 44,735 | 30,000,000 | PRN | | DFND | 1 | 30,000,000 | 0 | 0 |
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 31,308 | 3,933,137 | SH | | DFND | 1 | 3,933,137 | 0 | 0 |
ENVISTA HOLDINGS CORPORATION | NOTE 2.375% 6/0 | 29415FAB0 | 100,380 | 52,500,000 | PRN | | DFND | 1 | 52,500,000 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 22 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 9,900 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
EVOLUS INC | COM | 30052C107 | 42,140 | 3,632,751 | SH | | DFND | 1 | 3,632,751 | 0 | 0 |
FOGHORN THERAPEUTICS INC | COM | 344174107 | 10,574 | 777,525 | SH | | DFND | 1 | 777,525 | 0 | 0 |
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 56,684 | 89,036,000 | PRN | | DFND | 1 | 89,036,000 | 0 | 0 |
GILEAD SCIENCES INC | COM | 375558103 | 95,969 | 1,552,639 | SH | | DFND | 1 | 1,552,639 | 0 | 0 |
GLAUKOS CORP | NOTE 2.750% 6/1 | 377322AB8 | 324,465 | 271,752,000 | PRN | | DFND | 1 | 271,752,000 | 0 | 0 |
GLAUKOS CORP | COM | 377322102 | 47,215 | 1,039,514 | SH | | DFND | 1 | 1,039,514 | 0 | 0 |
GRAYBUG VISION INC | COM SHS | 38942Q103 | 5,757 | 5,281,713 | SH | | DFND | 1 | 5,281,713 | 0 | 0 |
HEALTH CATALYST INC | NOTE 2.500% 4/1 | 42225TAB3 | 13,452 | 15,000,000 | PRN | | DFND | 1 | 15,000,000 | 0 | 0 |
HILLEVAX INC | COM | 43157M102 | 28,614 | 2,617,948 | SH | | DFND | 1 | 2,617,948 | 0 | 0 |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 24,965 | 313,000 | SH | | DFND | 1 | 313,000 | 0 | 0 |
IGNYTE ACQUISITION CORP | *W EXP 01/05/202 | 45175H114 | 76 | 362,500 | SH | | DFND | 1 | 362,500 | 0 | 0 |
IGNYTE ACQUISITION CORP | COM | 45175H106 | 7,149 | 725,000 | SH | | DFND | 1 | 725,000 | 0 | 0 |
IMMUNOGEN INC | COM | 45253H101 | 67,592 | 15,020,490 | SH | | DFND | 1 | 15,020,490 | 0 | 0 |
INOZYME PHARMA INC | COM | 45790W108 | 12,862 | 2,696,372 | SH | | DFND | 1 | 2,696,372 | 0 | 0 |
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 70,460 | 75,000,000 | PRN | | DFND | 1 | 75,000,000 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | 18,941 | 960,484 | SH | | DFND | 1 | 960,484 | 0 | 0 |
INSULET CORP | NOTE 0.375% 9/0 | 45784PAK7 | 66,018 | 57,581,000 | PRN | | DFND | 1 | 57,581,000 | 0 | 0 |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 45845PAA6 | 56,158 | 57,791,000 | PRN | | DFND | 1 | 57,791,000 | 0 | 0 |
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 163,025 | 206,873,000 | PRN | | DFND | 1 | 206,873,000 | 0 | 0 |
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 116,991 | 127,800,000 | PRN | | DFND | 1 | 127,800,000 | 0 | 0 |
IVERIC BIO INC | COM | 46583P102 | 50,159 | 5,214,000 | SH | | DFND | 1 | 5,214,000 | 0 | 0 |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 11,735 | 1,419,000 | SH | | DFND | 1 | 1,419,000 | 0 | 0 |
KINNATE BIOPHARMA INC | COM | 49705R105 | 3,153 | 250,000 | SH | | DFND | 1 | 250,000 | 0 | 0 |
KURA ONCOLOGY INC | COM | 50127T109 | 48,153 | 2,627,000 | SH | | DFND | 1 | 2,627,000 | 0 | 0 |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 11,427 | 5,830,249 | SH | | DFND | 1 | 5,830,249 | 0 | 0 |
LIVONGO HEALTH INC | NOTE 0.875% 6/0 | 539183AA1 | 42,380 | 50,000,000 | PRN | | DFND | 1 | 50,000,000 | 0 | 0 |
MEDAVAIL HOLDINGS INC | COM | 58406B103 | 1,280 | 836,626 | SH | | DFND | 1 | 836,626 | 0 | 0 |
MEDTECH ACQUISITION CORP | UNIT 12/18/2025 | 58507N204 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
MEDTECH ACQUISITION CORP | COM CL A | 58507N105 | 9,845 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
MEDTECH ACQUISITION CORP | *W EXP 12/22/202 | 58507N113 | 28 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
MERUS N V | COM | N5749R100 | 44,961 | 1,985,924 | SH | | DFND | 1 | 1,985,924 | 0 | 0 |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 63,137 | 3,244,434 | SH | | DFND | 1 | 3,244,434 | 0 | 0 |
MOLINA HEALTHCARE INC | COM | 60855R100 | 46,695 | 167,000 | SH | | DFND | 1 | 167,000 | 0 | 0 |
NATERA INC | NOTE 2.250% 5/0 | 632307AB0 | 111,924 | 90,638,000 | PRN | | DFND | 1 | 90,638,000 | 0 | 0 |
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 5,443 | 6,500,000 | PRN | | DFND | 1 | 6,500,000 | 0 | 0 |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 196,199 | 2,012,714 | SH | | DFND | 1 | 2,012,714 | 0 | 0 |
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 57,724 | 61,000,000 | PRN | | DFND | 1 | 61,000,000 | 0 | 0 |
NKARTA INC | COM | 65487U108 | 7,392 | 600,000 | SH | | DFND | 1 | 600,000 | 0 | 0 |
NOVAVAX INC | NOTE 3.750% 2/0 | 670002AB0 | 24,855 | 25,000,000 | PRN | | DFND | 1 | 25,000,000 | 0 | 0 |
NUVALENT INC | COM | 670703107 | 262,264 | 19,341,024 | SH | | DFND | 1 | 19,341,024 | 0 | 0 |
NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 71,655 | 80,000,000 | PRN | | DFND | 1 | 80,000,000 | 0 | 0 |
NUVASIVE INC | NOTE 1.000% 6/0 | 670704AL9 | 93,615 | 96,966,000 | PRN | | DFND | 1 | 96,966,000 | 0 | 0 |
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 47 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
NYXOAH S A | SHS | B6S7WD106 | 4,188 | 455,262 | SH | | DFND | 1 | 455,262 | 0 | 0 |
ONCORUS INC | COM | 68236R103 | 3,968 | 3,148,977 | SH | | DFND | 1 | 3,148,977 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | *W EXP 11/15/202 | 68236X118 | 625 | 1,250,000 | SH | | DFND | 1 | 1,250,000 | 0 | 0 |
THE ONCOLOGY INSTITUTE INC | COM | 68236X100 | 17,118 | 3,383,099 | SH | | DFND | 1 | 3,383,099 | 0 | 0 |
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 4,060 | 6,949,416 | SH | | DFND | 1 | 6,949,416 | 0 | 0 |
ORGANOGENESIS HLDGS INC | COM | 68621F102 | 21,705 | 4,447,740 | SH | | DFND | 1 | 4,447,740 | 0 | 0 |
ORION ACQUISITION CORP | *W EXP 02/19/202 | 68626A116 | 11 | 125,000 | SH | | DFND | 1 | 125,000 | 0 | 0 |
ORION ACQUISITION CORP | COM CL A | 68626A108 | 4,900 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
OAK STR HEALTH INC | NOTE 3/1 | 67181AAB3 | 48,551 | 68,000,000 | SH | | DFND | 1 | 68,000,000 | 0 | 0 |
OUTSET MED INC | COM | 690145107 | 5,953 | 400,622 | SH | | DFND | 1 | 400,622 | 0 | 0 |
PACIRA BIOSCIENCES INC | COM | 695127100 | 17,024 | 292,000 | SH | | DFND | 1 | 292,000 | 0 | 0 |
PACIRA BIOSCIENCES INC | NOTE 0.750% 8/0 | 695127AF7 | 84,967 | 81,600,000 | PRN | | DFND | 1 | 81,600,000 | 0 | 0 |
PEPGEN INC | COM | 713317105 | 9,470 | 953,626 | SH | | DFND | 1 | 953,626 | 0 | 0 |
PHARVARIS N V | COM | N69605108 | 26,307 | 1,190,343 | SH | | DFND | 1 | 1,190,343 | 0 | 0 |
PHREESIA INC | COM | 71944F106 | 21,436 | 857,115 | SH | | DFND | 1 | 857,115 | 0 | 0 |
PROFOUND MED CORP | COM NEW | 74319B502 | 12,494 | 1,713,797 | SH | | DFND | 1 | 1,713,797 | 0 | 0 |
PTC THERAPEUTICS INC | NOTE 3.000% 8/1 | 69366JAB7 | 25,518 | 25,417,000 | PRN | | DFND | 1 | 25,417,000 | 0 | 0 |
PTC THERAPEUTICS INC | NOTE 1.500% 9/1 | 69366JAD3 | 33,439 | 32,000,000 | PRN | | DFND | 1 | 32,000,000 | 0 | 0 |
PULMONX CORP | COM | 745848101 | 51,018 | 3,465,901 | SH | | DFND | 1 | 3,465,901 | 0 | 0 |
QUANTUM SI INC | COM CL A | 74765K105 | 3,248 | 1,400,000 | SH | | DFND | 1 | 1,400,000 | 0 | 0 |
QUANTUM SI INC | *W EXP 06/10/202 | 74765K113 | 188 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 9,770 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 49 | 200,000 | SH | | DFND | 1 | 200,000 | 0 | 0 |
REVOLUTION MEDICINES INC | COM | 76155X100 | 17,377 | 891,587 | SH | | DFND | 1 | 891,587 | 0 | 0 |
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,208 | 291,005 | SH | | DFND | 1 | 291,005 | 0 | 0 |
ROIVANT SCIENCES LTD | *W EXP 09/30/202 | G76279119 | 600 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 0 | 1 | SH | | DFND | 1 | 1 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 9,890 | 999,999 | SH | | DFND | 1 | 999,999 | 0 | 0 |
SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 33 | 333,333 | SH | | DFND | 1 | 333,333 | 0 | 0 |
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 23,749 | 18,848,488 | SH | | DFND | 1 | 18,848,488 | 0 | 0 |
SENIOR CONNECT ACQUISITN COR | *W EXP 12/31/202 | 81723H116 | 35 | 500,000 | SH | | DFND | 1 | 500,000 | 0 | 0 |
SENIOR CONNECT ACQUISITN COR | COM CL A | 81723H108 | 9,840 | 1,000,000 | SH | | DFND | 1 | 1,000,000 | 0 | 0 |
SILK RD MED INC | COM | 82710M100 | 97,412 | 2,676,891 | SH | | DFND | 1 | 2,676,891 | 0 | 0 |
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 24,205 | 6,336,330 | SH | | DFND | 1 | 6,336,330 | 0 | 0 |
SOMALOGIC INC | *W EXP 08/31/202 | 83444K113 | 91 | 120,000 | SH | | DFND | 1 | 120,000 | 0 | 0 |
SAREPTA THERAPEUTICS INC | DBCV 1.500%11/1 | 803607AB6 | 111,766 | 88,657,000 | SH | | DFND | 1 | 88,657,000 | 0 | 0 |
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 32 | 166,666 | SH | | DFND | 1 | 166,666 | 0 | 0 |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 21,378 | 1,111,111 | SH | | DFND | 1 | 1,111,111 | 0 | 0 |
TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 873379AA9 | 97,174 | 144,516,000 | PRN | | DFND | 1 | 144,516,000 | 0 | 0 |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 19,334 | 1,324,214 | SH | | DFND | 1 | 1,324,214 | 0 | 0 |
TG THERAPEUTICS INC | COM | 88322Q108 | 11,379 | 2,677,500 | SH | | DFND | 1 | 2,677,500 | 0 | 0 |
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 19 | 250,000 | SH | | DFND | 1 | 250,000 | 0 | 0 |
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 7,448 | 750,000 | SH | | DFND | 1 | 750,000 | 0 | 0 |
VIATRIS INC | COM | 92556V106 | 216,454 | 20,673,700 | SH | | DFND | 1 | 20,673,700 | 0 | 0 |
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 3,919 | 958,125 | SH | | DFND | 1 | 958,125 | 0 | 0 |
WINDTREE THERAPEUTICS INC | COM | 97382D303 | 8 | 20,148 | SH | | DFND | 1 | 20,148 | 0 | 0 |
XERIS BIOPHARMA HOLDINGS INC | NOTE 5.000% 7/1 | 98422LAA5 | 17,607 | 18,000,000 | PRN | | DFND | 1 | 18,000,000 | 0 | 0 |
XILIO THERAPEUTICS INC | COM | 98422T100 | 6,070 | 2,078,692 | SH | | DFND | 1 | 2,078,692 | 0 | 0 |